Trachoma as cause of blindness: literature review

  • Maria Beatriz Araújo Silva
  • Maria Sandra Andrade
  • Yohana Véras de Oliveira
  • Maria Gabriela Santiago Marques
  • Clarissa Mourão Pinho
  • Katiuscia Araújo de Miranda Lopes

Abstract

This is a literature review that used as database articles in websites like Bireme, SciELO, LILACS, Journals and Webartigos. Development: Trachoma is an ocular inflammatory disease, whose etiological agent is Chlamydia trachomatis, which affects the conjunctiva and cornea causing a chronic relapsing keratoconjunctivitis, in the course of time may lead to the formation of entropion, trichiasis and possible blindness. Its transmission occurs in the home environment, directly or indirectly. The occurrence of trachoma is mostly where hygiene and lifestyle habits are precarious. According to the World Health Organization, there are six million people currently infected. Conclusion: The study shows the importance of knowledge about trachoma, so that Brazil is able to achieve the global goal of eliminating the disease by 2020.

References

1. Araújo FAM, Cruz AAV. Alterações de cílios no Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto-USP. Arq Bras Oftalmol 2002; 65:343-9.
2. World Health Organization. Report of the 2nd Global Scientific Meeting on Trachoma.Geneva, 25-27 August, 2003. Geneva: WHO; 2003.
3. BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Guia de vigilância epidemiológica / Ministério da Saúde, Secretaria de Vigilância em Saúde. – 6. ed. – Brasília: Ministério da Saúde, 2005.
4. Schellini SA, Sousa RLF. Tracoma: ainda uma importante causa de cegueira. Rev Bras Oftalmol 2012; 71 (3): 199-204.
5. BRASIL Ministério da Saúde. Secretaria de Vigilância em Saúde, Departamento de Vigilância em Doenças Transmissíveis. Plano integrado de ações estratégicas de eliminação da hanseníase, filariose, esquistossomose e oncocercose como problema de saúde pública, tracoma como causa de cegueira e controle das geohelmintíases: plano de ação 2011-2015 / Ministério da Saúde, Brasília: Ministério da Saúde, versão 2012.
6. Lucena AR, Cruz AAV, Akaishi P. Epidemiologia do tracoma em povoado da chapada do Araripe Pernambuco – Brasil. Arq Bras Oftalmol 2003; 67:197-200.
7. Spegiorin-Júnior WR. Incidência do Tracoma nos Escolares do Município de Ribas do Rio Pardo. Ribas do Rio Pardo: Universidade Federal de Mato Grosso do Sul; 2011. 10p.
8. D’Amaral RKK, Cardoso MRA, Medina NH, Cunha ICKO, Waldman EA. Fatores associados ao tracoma em área hipoendêmica da Região Sudeste, Cad. Saúde Pública, Rio de Janeiro, 21(6):1701-1708, nov-dez, 2005.
9. BRASIL Ministério da Saúde. Fundação Nacional de Saúde. Manual de Controle do Tracoma Brasília, versão 2001.
10. Taylor HR. Trachoma: A blinding scourge from the Bronze Age to the twenty-first century. Melbourne: Centre for Eye Research Australia, 2008.

11. Cruz AAV, Medina NH, Gonçalves GFOR, Gomes UA. Distribuição espacial e determinantes sociais do tracoma na cidade de São Gabriel da Cachoeira - AM. ArqBras Oftalmol. 2001;64(4):5.
12. Neftálli DM, Shayanne RR, Álvaro HMB. Alta incidência de contaminação por Tracoma em Crianças e Adultos. Transinf [Internet]. 2013 [acesso em 2015 jun 10]; 4p. Disponível em: http://www.webartigos.com/artigos/alta-incidencia-de-contaminacao-por-tracoma-em-criancas-e-adultos/106857/
13. WHO. Trachoma: status of endemicity for blinding trachoma by country 2013. http://apps.who.int/gho/data/node.main.A1645 (accessed Feb 26, 2016).

14. WHO. Report of the 3rd global scientifi c meeting on trachoma elimination (Johns Hopkins University, Baltimore, Maryland; 19–20 July, 2010). http://www.who.int/blindness/publications/3RDGLOBAL SCIENTIFICMEETINGONTRACHOMA.pdf (accessed Feb 26, 2016).

15. Kasper D, Fauci A. Infecções Bacterianas. Doenças Infecciosas de Harrison. AMGH Editora 2015; 2.ed:626-628.
16. Goldman L, Schafer AI. Doenças Causadas por Clamídias. Goldman Cecil Medicina Interna. Elsevier Brasil 2014,1.ed:326-329.
17. Clarke IN. Evolution of Chlamydia trachomatis. Ann N Y Acad Sci 2011; 1230: E11–18.

18. Carlson JH, Porcella SF, McClarty G, Caldwell HD. Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. Infect Immun 2005; 73: 6407–18.

19. West SK, Munoz B, Turner VM, Mmbaga BBO, Taylor HR. The epidemiology of trachoma in central Tanzania. Int J Epidemiol 199; 20: 1088–92.

20. Ngondi J, Onsarigo A, Adamu L, et al. The epidemiology of trachoma in Eastern Equatoria and Upper Nile States, southern Sudan. Bull World Health Organ 2005; 83: 904–12.

21. Ngondi J, Gebre T, Shargie EB, et al. Evaluation of three years of the SAFE strategy (Surgery, Antibiotics, Facial cleanliness and Environmental improvement) for trachoma control in five districts of Ethiopia hyperendemic for trachoma. Trans R Soc Trop Med Hyg 2009; 103: 1001–10.

22. Hu VH, Holland MJ, Burton MJ. Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis. PLoS Negl Trop Dis 2013; 7: e2020.

23. el-Asrar AM, Van den Oord JJ, Geboes K, Missotten L, Emarah MH, Desmet V. Immunopathology of trachomatous conjunctivitis. Br J Ophthalmol 1989; 73: 276–82.

24. Lopes MFC, Luna EJA, Medina NH, Cardoso MRA, Freitas HSA, Koizumi IK, et al. Prevalência de tracoma entre escolares brasileiros. Rev Saúde Pública 2013;47(3):451-9.
25. Natividad A, Freeman TC, Jeffries D, et al. Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection. Infect Immun 2010; 78: 4895–911

26. Wolle MA, Munoz BE, Mkocha H, West SK. Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania. Ophthalmology 2009; 116: 243–47.

27. Bobo LD, Novak N, Munoz B, Hsieh YH, Quinn TC, West S. Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection. J Infect Dis 1997; 176: 1524–30.

28. West SK, Munoz B, Lynch M, Kayongoya A, Mmbaga BBO, Taylor HR. Risk factors for constant, severe trachoma among preschool children in Kongwa, Tanzania. Am J Epidemiol 1996; 143: 73–78.

29. West SK, Munoz B, Mkocha H, Hsieh YH, Lynch MC. Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol 2001; 8: 137–44.

30. Burton MJ, Holland MJ, Makalo P, et al. Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities. PLoS Negl Trop Dis 2010; 4: 1–10.

31. Hu VH, Massae P, Weiss HA, et al. Bacterial infection in scarring trachoma. Invest Ophthalmol Vis Sci 2011; 52: 2181–86.

32. Burton MJ, Bailey RL, Jeff ries D, Mabey DCW, Holland MJ. Cytokine and fi brogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic. Infect Immun 2004; 72: 7352–56.

33. Burton MJ, Rajak SN, Bauer J, et al. Conjunctival transcriptome in scarring trachoma. Infect Immun 2011; 79: 499–511.

34. Bowman RJC, Faal H, Myatt M, et al. Longitudinal study of trachomatous trichiasis in the Gambia. Br J Ophthalmol 2002; 86: 339–43.

35. Frick KD, Melia BM, Buhrmann RR, West SK. Trichiasis and disability in a trachoma-endemic area of Tanzania. Arch Ophthalmol 2001; 119: 1839–44.

36. Dhaliwal U, Nagpal G, Bhatia MS. Health-related quality of life in patients with trachomatous trichiasis or entropion. Ophthalmic Epidemiol 2006; 13: 59–66.

37. Renato WFD, Rodrigo RS, Thiago RTC, Richard YH, Mário JS, Andréa MCset al. Tracoma: estudo epidemiológico de escolares em Alagoas – Brasil . ArqBras Oftalmol. 2009;72(3):355-9.
38. Lucieni CBF, Silvana AS, Carlos RP, Norma HM, Ivete D. Tracoma em crianças do ensino fundamental no município de Bauru - Estado de São Paulo, Brasil. ArqBras Oftalmol. 2010;73(5):433-7.
39. Chidambaram JD, Alemayehu W, Melese M, et al. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA 2006; 295: 1142–46.

40. Schachter J, West SK, Mabey D, et al. Azithromycin in control of trachoma. Lancet 1999; 354: 630–35.

41. West SK, Munoz B, Mkocha H, et al. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 2005; 366: 1296–300.

42. Burton MJ, Holland MJ, Makalo P, et al. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet 2005; 365: 1321–28.

43. Solomon AW, Holland MJ, Alexander NDE, et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med 2004; 351: 1962–71.

44. Keenan JD, Lakew T, Alemayehu W, et al. Slow resolution of clinically active trachoma following successful mass antibiotic treatments. Arch Ophthalmol 2011; 129: 512–13.

45. Munoz B, Stare D, Mkocha H, Gaydos C, Quinn T, West SK. Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection? Invest Ophthalmol Vis Sci 2011; 52: 8806–10.

46. Rajak SN, Collin JRO, Burton MJ. Trachomatous trichiasis and its management in endemic countries. Surv Ophthalmol 2012; 57: 105–35.

47. Reacher MH, Munoz B, Alghassany A, Daar AS, Elbualy M, Taylor HR. A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol 1992; 110: 667–74

48. Burton MJ, Kinteh F, Jallow O, et al. A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia. Br J Ophthalmol 2005; 89: 1282–88.

49. Woreta TA, Munoz BE, Gower EW, Alemayehu W, West SK. Effect of trichiasis surgery on visual acuity outcomes in Ethiopia. Arch Ophthalmol 2009; 127: 1505–10.

50. Rajak SN, Habtamu E, Weiss HA, et al. Absorbable versus silk sutures for surgical treatment of trachomatous trichiasis in Ethiopia: a randomised controlled trial. PLoS Med 2011; 8: e1001137.

51. West SK, West ES, Alemayehu W, et al. Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia. Arch Ophthalmol 2006; 124: 309–14.

52. Khandekar R, Mohammed AJ, Courtright P. Recurrence of trichiasis: a long-term follow-up study in the Sultanate of Oman. Ophthalmic Epidemiol 2001; 8: 155–61.

53. Thanh TTK, Khandekar R, Luong VQ, Courtright P. One year recurrence of trachomatous trichiasis in routinely operated Cuenod Nataf procedure cases in Vietnam. Br J Ophthalmol 2004; 88: 1114–18.

54. Burton MJ, Bowman RJC, Faal H, et al. Long term outcome of trichiasis surgery in the Gambia. Br J Ophthalmol 2005; 89: 575–79.

55. Ezz al Arab G, Tawfi k N, El Gendy R, Anwar W, Courtright P. The burden of trachoma in the rural Nile Delta of Egypt: a survey of Menofi ya governorate. Br J Ophthalmol 2001; 85: 1406–10.

56. Rajak SN, Makalo P, Sillah A, et al. Trichiasis surgery in The Gambia: a 4-year prospective study. Invest Ophthalmol Vis Sci 2010; 51: 4996–5001.

57. Broman AT, Shum K, Munoz B, Duncan DD, West SK. Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania. Invest Ophthalmol Vis Sci 2006; 47: 99–104

58. Emerson PM, Lindsay SW, Alexander N, et al. Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial. Lancet 2004; 363: 1093–98.

59. Courtright P, Sheppard J, Lane S, Sadek A, Schachter J,Dawson CR. Latrine ownership as a protective factor ininflammatory trachoma in Egypt. Br J Ophthalmol 1991; 75: 322–25.

60. Bailey R, Osmond C, Mabey DCW, Whittle HC, Ward ME. Analysisof the household distribution of trachoma in a Gambian villageusing a Monte Carlo simulation procedure. Int J Epidemiol 1989;18: 944–51.

61. Taylor HR, Rapoza PA, West S, et al. The epidemiology of infection in trachoma. Invest Ophthalmol Vis Sci 1989; 30: 1823–33.

62. Schemann J-F, Sacko D, Malvy D, et al. Risk factors for trachoma in Mali. Int J Epidemiol 2002; 31: 194–201.

63. West S, Munoz B, Lynch M, et al. Impact of face-washing on trachoma in Kongwa, Tanzania. Lancet 1995; 345: 155–58.

64. West S, Lynch M, Turner V, et al. Water availability and trachoma. Bull World Health Organ 1989; 67: 71–75

65. Montgomery MA, Bartram J. Short-sightedness in sight-saving: half a strategy will not eliminate blinding trachoma. Bull World Health Organ 2010; 88: 82.

66. Departamento de Ciência e Tecnologia, Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Ministério da Saúde. Doenças negligenciadas: estratégias do Ministério da Saúde. Rev Saúde Pública 2010; 44(1):200-2.
Published
2017-02-21
How to Cite
ARAÚJO SILVA, Maria Beatriz et al. Trachoma as cause of blindness: literature review. International Archives of Medicine, [S.l.], v. 10, feb. 2017. ISSN 1755-7682. Available at: <http://imedicalsociety.org/ojs/index.php/iam/article/view/2341>. Date accessed: 25 sep. 2017. doi: https://doi.org/10.3823/2326.
Section
Ophthalmology

Most read articles by the same author(s)